These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 1089381)
1. Blood-its derivatives and its problems--factor IX. Kasper CK Ann N Y Acad Sci; 1975 Jan; 240():172-80. PubMed ID: 1089381 [No Abstract] [Full Text] [Related]
2. Jaundice and hepatitis B antigen-antibody in hemophilia. Lewis JH; Maxwell NG; Brandon JM Transfusion; 1974; 14(3):203-11. PubMed ID: 4835949 [No Abstract] [Full Text] [Related]
3. Recipient's hepatitis, an inevitable side-effect of blood transfusion. Fiedler H Vox Sang; 1974; 26(4):368-73. PubMed ID: 4842157 [No Abstract] [Full Text] [Related]
4. Post-transfusion hepatits following the use of prothrombin complex concentrates. Roberts HR; Blatt PM Thromb Diath Haemorrh; 1975 Jun; 33(3):610-6. PubMed ID: 1154316 [No Abstract] [Full Text] [Related]
5. Concentration of hepatitis-B antigen from clinical preparations of II, VII, IX and X by polyethylene glycol, to enhance detection and removal. Johnson AJ Ann N Y Acad Sci; 1975 Jan; 240():162-4. PubMed ID: 234215 [No Abstract] [Full Text] [Related]
6. Serologic evidence of hepatitis B virus infection in patients with hemophilia B. a multicenter study. Hoofnagle JH; Aronnon D; Roberts H Thromb Diath Haemorrh; 1975 Jun; 33(3):606-9. PubMed ID: 1154315 [TBL] [Abstract][Full Text] [Related]
7. Antithrombin-III transfusion in disseminated intravascular coagulation. Blatt PM; White GC; Goldsmith JC; Roberts HR Lancet; 1978 Jun; 1(8075):1212. PubMed ID: 77980 [No Abstract] [Full Text] [Related]
12. Transfusions of blood and blood components. Mayer K Crit Care Med; 1974; 2(3):118-22. PubMed ID: 4837482 [No Abstract] [Full Text] [Related]
13. Detection of HBsAg in coagulation Factor IX concentrates. O'Connor ML; Meek ES; Simmons A Transfusion; 1977; 17(1):44-6. PubMed ID: 841671 [TBL] [Abstract][Full Text] [Related]
14. Prothrombin complex concentrates: clinical use. Menache D Ann N Y Acad Sci; 1981; 370():747-56. PubMed ID: 6791551 [No Abstract] [Full Text] [Related]
15. The Ausria test: critical evaluation of sensitivity and specificity. Alter HJ; Holland PV; Purcell RH; Gerin JL Blood; 1973 Dec; 42(6):947-57. PubMed ID: 4202455 [No Abstract] [Full Text] [Related]
16. Factor IX thrombogenicity: in vivo effects on coagulation activation and a case report of disseminated intravascular coagulation. Small M; Lowe GD; Douglas JT; Forbes CD; Prentice CR Thromb Haemost; 1982 Aug; 48(1):76-7. PubMed ID: 7135346 [TBL] [Abstract][Full Text] [Related]
17. Transmission of viral hepatitis, type B, by plasma derivatives. Barker LF; Hoofnagle JH Dev Biol Stand; 1974; 27():178-88. PubMed ID: 4142771 [No Abstract] [Full Text] [Related]
19. Properties of commercial factor IX concentrates. Coan MH; Fournel MA; Mozen MM Ann N Y Acad Sci; 1981; 370():731-46. PubMed ID: 6168231 [No Abstract] [Full Text] [Related]
20. Removal of hepatitis B surface antigen (HBsAg) from plasma fractions. Johnson AJ; Semar M; Newman J; Harris RB; Brandt D; Middleton S; Smith J J Lab Clin Med; 1976 Jul; 88(1):91-101. PubMed ID: 932537 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]